The incidence and mortality of hepatocellular carcinoma (HCC) have fallen dramatically in
China and elsewhere over the past several decades. Nonetheless, HCC remains a major …

Simple Summary The use of branched-chain amino acid (BCAA) supplements in patients
with cirrhosis and liver cancer has been investigated by numerous studies, with multiple …

Aim To elucidate the clinical significance of muscle wasting in regard to survival of
hepatocellular carcinoma (HCC) patients undergoing sorafenib treatment, we evaluated …

Background and Aim Sarcopenia, initially proposed as decreased of muscle mass and
strength, is associated with aging and malignant diseases. The aim of the present study was …

Our study investigated the correlation between sarcopenia and clinical outcomes in patients
with hepatocellular carcinoma (HCC) treated with lenvatinib. We retrospectively evaluated …

Sarcopenia is associated with poor prognosis of patients with hepatocellular carcinoma
(HCC). We investigated the association of skeletal muscle volume (SMV) and its change in …

Background Dietary supplementation with branched‐chain amino acids (BCAA) is often
used in cirrhotic patients to improve nutritional status. We wanted to explore the evidence for …

Aim As second‐line therapy, regorafenib has been shown to provide a survival benefit for
patients with hepatocellular carcinoma (HCC) who progress on sorafenib. In this …

Aim This study aimed to investigate liver functional reserves during sorafenib treatment for
advanced hepatocellular carcinoma (HCC), to identify predictive factors for maintaining …

In cancer patients, loss of muscle mass is significantly associated with low tolerability of
chemotherapy and poor survival. Despite the great strides in the treatment of cancer …